Apellis Pharma Inc - APLS - stock price prediction, stock price target, analyst ratings from 23 analysts

Apellis Pharma Inc has a share price target of US$ 34, revenue growth forecast of -13.8%, and profit growth estimate of -755.2% for FY26, based on top 23 analyst calls.